Mitorainbow Therapeutics, Inc.

Biotechnology company · Cary, North Carolina, United States

Mitorainbow Therapeutics, Inc. is a biotechnology company headquartered in Cary, North Carolina, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Mitorainbow Therapeutics at a glance

Typebiotechnology company
HeadquartersCary, North Carolina, United States
Employees (self-reported, 2022)3

What does Mitorainbow Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.8 million in total (2022). NIH funding came from the National Institute of General Medical Sciences.

Frequently asked questions about Mitorainbow Therapeutics

Where is Mitorainbow Therapeutics headquartered?

Mitorainbow Therapeutics, Inc. is headquartered in Cary, North Carolina, United States.

What does Mitorainbow Therapeutics do?

Mitorainbow Therapeutics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences